Please ensure Javascript is enabled for purposes of website accessibility

Why 22nd Century Group Stock Just Lit Up

By Rich Smith - Mar 12, 2021 at 1:55PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Tobacco and marijuana bioengineering? Yeah, that's apparently a thing now.

What happened

Shares of 22nd Century Group (XXII -7.33%) are up a strong 14.6% in 11:45 a.m. EST trading Friday after the "plant biotechnology" company reported fourth-quarter earnings yesterday.

22nd Century Group didn't "beat" earnings, exactly. Its $0.05 per-share reported loss was worse than the $0.03 loss predicted by the sole analyst who covers it. But the company's $7.3 million in sales for the quarter did beat the analyst's predictions for sales -- $6 million.  

Rising red stock arrow on a yellow background.

Image source: Getty Images.

So what

22nd Century Group isn't a very well-known stock. I actually don't think we've ever written about it before, so perhaps an introduction is in order. The company uses genetic engineering to tweak the levels of nicotine and cannabinoids produced by tobacco and cannabis plants, respectively, aiming to find a niche within what it calls "the more than $800 billion markets across the tobacco and hemp/cannabis industry."  

22nd Century says it expects the Biden administration will seek "to cap the amount of nicotine in combustible cigarettes to a 'minimally or non-addictive' level" in order to decrease smoking in the country. That sounds like bad news for tobacco stocks in general but maybe good news for 22nd Century, whose technology could be helpful for this.

Now what

Management did not give financial guidance for the coming year. However, in 2021, the company says it will be seeking FDA authorization for its VLN "reduced nicotine content combustible cigarette," which it says would satisfy a requirement that cigarettes contain no more than 0.5 milligrams of nicotine per gram of tobacco. 22nd Century is also hoping "to target the upstream segment of the cannabinoid value chain by creating proprietary, commercially valuable new plant lines" as marijuana legalization progresses in the U.S.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

22nd Century Group, Inc. Stock Quote
22nd Century Group, Inc.
$1.77 (-7.33%) $0.14

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/19/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.